ESC 2024 Insights

 

Videos
12:36

ESC 2024 Insights

ESC 2024 Insights: WITHDRAWal of Heart Failure Pharmacotherapy in Patients with Normalized Left Ventricular Function After AF Rhythm Control in Arrhythmia Induced Cardiomyopathy-The WITHDRAW-AF Randomized Clinical Trial

FEATURING Louise Segan
  • 1 view
  • November 7, 2024
08:09

ESC 2024 Insights

ESC 2024 Insights: Impact of Baseline Surgical Risk on the Treatment Effect of PCI and CABG in Ischemic Left Ventricular Systolic Dysfunction - Results of the REVIVED-BCIS2 and STICH Randomized Controlled Trials

FEATURING Guillaume Marquis-Gravel
  • November 4, 2024
07:23

ESC 2024 Insights

ESC 2024 Insights: Comparison of Different Calcium Modification Strategies for Coronary Calcium Nodules - Insights from Optical Coherence Tomography

FEATURING Keisuke Yasumura
  • 64 views
  • October 23, 2024
  • 2
12:15

ESC 2024 Insights

ESC 2024 Insights: 2022 ESC Guidelines on Cardio-Oncology: What Do the Guidelines Say and How to Implement the Guidelines?

FEATURING Riccardo Asteggiano
  • 5 views
  • October 22, 2024
08:01

ESC 2024 Insights

ESC 2024 Insights: Synchronized Left Ventricular Pacing Improves Cardiac Resynchronization Therapy Outcomes: Insights from AdaptResponse

FEATURING David Birnie
  • 7 views
  • October 22, 2024
07:49

ESC 2024 Insights

ESC 2024 Insights: Pulsed ElectRic FiEld vs Cryoballoon to Treat Paroxysmal Atrial Fibrillation (PERFECT-PAF) Randomized Trial: a Periprocedural Clinical and Cost Analysis

FEATURING Gian Battista Chierchia
  • 370 views
  • October 11, 2024
  • 2
09:25

ESC 2024 Insights

ESC 2024 Insights: Apixaban vs Clopidogrel on a Background of Aspirin in Patient Undergoing Infrapopliteal Angioplasty for Critical Limb Ischemia - AGRIPPA Trial

  • 88 views
  • October 7, 2024
11:54

ESC 2024 Insights

ESC 2024 Insights: LDL-Cholesterol Levels and Lipid Lowering Therapy in Secondary Prevention Patients: Preliminary Data from BRING-UP Prevention Study

FEATURING Aldo Maggioni
  • 1,690 views
  • October 3, 2024
  • 7
09:56

ESC 2024 Insights

ESC 2024 Insights: Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Fibrillation or Tachycardia - AFLOAT

FEATURING Gilles Montalescot
  • 37 views
  • September 30, 2024
14:19

ESC 2024 Insights

ESC 2024 Insights: State-of-the-Art Lecture on Calcium Modification: Optimising the Journey Through Coronary Calcium

FEATURING Annapoorna Kini
  • 83 views
  • September 30, 2024
  • 1
11:37

ESC 2024 Insights

ESC 2024 Insights: Manual Chest PRESSURE During Direct Current Cardioversion for Atrial Fibrillation: a Randomized Control Trial (PRESSURE-AF)

FEATURING David Ferreira
  • 263 views
  • September 27, 2024
  • 2
12:09

ESC 2024 Insights

ESC 2024 Insights: MATTERHORN - Transcatheter vs Surgical Mitral Valve Repair in Patients with Heart Failure and Secondary Mitral Regurgitation

FEATURING Volker Rudolph
  • 384 views
  • September 27, 2024
  • 1
09:12

ESC 2024 Insights

ESC 2024 Insights: Clopidogrel vs Aspirin Monotherapy Beyond 1-Month After PCI with DES: Final 1-Year Results from the STOPDAPT-3

FEATURING Hirotoshi Watanabe
  • 9 views
  • September 27, 2024
12:03

ESC 2024 Insights

ESC 2024 Insights: The TRI-SCORE: Impact in Daily Practice

FEATURING Julien Dreyfus
  • 162 views
  • September 27, 2024
10:14

ESC 2024 Insights

ESC 2024 Insights: Sacubitril/Valsartan Compared to Valsartan in Regressing Myocardial Fibrosis in Stage B Heart Failure: the REVERSE-LVH Trial

FEATURING Calvin Chin
  • 281 views
  • September 27, 2024
  • 2
18:02

ESC 2024 Insights

ESC 2024 Insights: Short- and Long-Term Effects of Beta-blockers on Symptoms of Anxiety and Depression in Patients with Myocardial Infarction and Preserved Left Ventricular Function

FEATURING Philip Leissner
  • 109 views
  • September 24, 2024
  • 2
17:45

ESC 2024 Insights

ESC 2024 Insights: Refining the CHA2DS2VASc Risk Stratification Scheme: Shall We Drop the Sex Category?

FEATURING Rui Providencia
  • 66 views
  • September 23, 2024
07:38

ESC 2024 Insights

ESC 2024 Insights: Effect of Aficamten on Cardiac Structure and Function in Patients With Obstructive Cardiomyopathy: The SEQUOIA-HCM CMR Trial

FEATURING Ahmad Masri
  • 113 views
  • September 23, 2024
  • 2
09:55

ESC 2024 Insights

ESC 2024 Insights: Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation: Results of the Phase 3 RESTORE-1 Trial

FEATURING Michiel Rienstra
  • 134 views
  • September 23, 2024
  • 1
13:01

ESC 2024 Insights

ESC 2024 Insights: The CAMERA-MRI 2 Randomized Clinical Trial. Catheter Ablation vs Medical Rate Control in Atrial Fibrillation with Left Ventricular Systolic Dysfunction and Myocardial Fibrosis

FEATURING Sandeep Prabhu
  • 73 views
  • September 23, 2024
15:11

ESC 2024 Insights

ESC 2024 Insights: Effect of Aficamten on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCM

FEATURING John Spertus
  • 31 views
  • September 23, 2024
08:27

ESC 2024 Insights

ESC 2024 Insights: SAVR and TAVI Comparison Across the Globe Based on Current Regional Registry Evidence

FEATURING Torsten Doenst
  • 122 views
  • September 20, 2024
  • 1
10:41

ESC 2024 Insights

ESC 2024 Insights: Major Adverse Cardiovascular Events, New Diagnoses, Prescription Redemptions and Outpatient Visits in Patients One Year After Evaluation for Symptoms Suggestive of Chronic Coronary Syndrome

FEATURING Morten Böttcher
  • 99 views
  • September 20, 2024
  • 2
15:36

ESC 2024 Insights

ESC 2024 Insights: Long-Term Effect of Biodegradable vs Durable Polymer DES on Neoatherosclerosis Among STEMI Patients: the CONNECT Trial

FEATURING Jonas Haener
  • 11 views
  • September 19, 2024